Brief: Sernova Says It Receives Second Tranche Equity Investment Of $6.8 Mln
Sept 1 (Reuters) - Sernova Corp SVA.TO :
* SERNOVA RECEIVES SECOND TRANCHE EQUITY INVESTMENT FROM
EVOTEC OF
$6.8 MILLION AT A PRICE OF $2.50 PER SHARE
Source text for Eikon: ID:nGNX4Svn96
Further company coverage: SVA.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sernova Biotherapeutics
See all newsBrief: Seraxis And Sernova Announce Appointment Of Former FDA Medical Officer Dr. Patricia Beaston As Chief Medical Officer Of Seraxis And Post Merger Betanova Biotherapeutics
Brief: Sernova Appoints Jonathan Rigby As Interim Chair
Brief: Sernova Biotherapeutics Provides Positive Interim Data From Ongoing Phase 1/2 Clinical Trial Of Cell Pouch Bio-Hybrid Organ In Patients Living With Type 1 Diabetes
Brief: Sernova Biotherapeutics Secures $4 Million Loan To Further Advance Its Clinical Development Plans
Brief: Sernova Biotherapeutics Inc Study Is On Track To Meet Key Clinical Trial Endpoints